Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates
Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation
Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation
The Biosphere, a specialist lab facility on Newcastle Helix, has welcomed yet another Newcastle